Search results
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
FX Empire via Yahoo Finance· 6 hours agoThe past five days have been a rollercoaster for Novavax investors, as the share price of the...
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 7 hours agoThe biotech soared 190% in two trading sessions after announcing a $1.2 billion vaccine-licensing...
Sanofi boosts French biomanufacturing with €1 billion investment By Investing.com
Investing.com· 2 days agoSanofi (EPA:SASY) (NASDAQ:SNY), a global biopharmaceutical company, announced today a significant...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 1 day agoSanofi has announced an investment exceeding €1bn ($1.07bn) to expand biomanufacturing capacities at...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 1 day agoNovavax stock nearly tripled over two days in May after inking a roughly $1.3 billion licensing deal...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 2 days agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi
Investing.com· 3 days agoNovavax , Inc. (NASDAQ: NVAX ) has entered into a multibillion-dollar global co-development and...
Earnings call: Fulcrum Therapeutics partners with Sanofi on FSHD drug
Investing.com· 1 day agoFulcrum Therapeutics (ticker: NASDAQ: FULC ) has entered into a significant collaboration with ...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 5 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
The Motley Fool via AOL· 1 day agoShares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday, May 10. The market was responding to terrific news from Sanofi (NASDAQ: SNY ...